Wyświetlanie pozycji 1-1 z 1

    • Gut microbial predictors of firstline immunotherapy efficacy in advanced NSCLC patients 

      Grenda, Anna; Iwan, Ewelina; Kuźnar-Kamińska, Barbara; Bomba, Arkadiusz; Bielińska, Katarzyna; Krawczyk, Paweł; Chmielewska, Izabela; Frąk, Małgorzata; Szczyrek, Michał; Rolska-Kopińska, Anna; Jankowski, Tomasz; Kieszko, Robert; Milanowski, Janusz (Nature, 2025)
      The composition of the gut microbiome of patients with advanced non-small cell lung cancer is currently considered a factor influencing the effectiveness of treatment with immune checkpoint inhibitors. We aimed to evaluate ...